Nyrada Inc (nyr) Logo

Nyrada Inc (NYR)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

NYR ASX Chart

Snapshot

Nyrada is a drug discovery and development company specializing in novel small molecule drugs to treat neurological and cardiovascular diseases. The Company has two main programs, each targeting market sectors of significant size and considerable unmet clinical need. These are a drug to treat brain injury, specifically traumatic brain injury and stroke, and a cholesterol lowering drug.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) +115.87%
vs ASX 200 (1yr) +118.86%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,768 of 2,358
Sector Rank 172 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies AGH / ANR / TRI
EPS -$0.032
DPS $0.00
Book Value Per Share $0.03

Broker Consensus

NYR is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Gordon NSW 2072
Website www.nyrada.com
Registry Automic Group
Auditor William Buck Audit (VIC) Pty Ltd
Date Listed 16 Jan 2020

Upcoming Calendar (Forecasted)

Date Event
12/11/2024 AGM
18/02/2025 Report (Interim)
21/08/2025 Report (Prelim)
21/08/2025 Report (Annual)

Former Company Names

  • Nyrada Inc has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

NYR directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
12/06/24 John Moore Issued 1,333,333 $0.075 $99,999 Placement
12/06/24 Marcus Frampton Issued 933,333 $0.075 $69,999 Placement
12/06/24 Ruediger Weseloh Issued 266,666 $0.075 $19,999 Placement
12/06/24 Ian Dixon Issued 266,666 $0.075 $19,999 Placement
14/03/24 Christopher Cox Expiry 600,000 $0.10 $60,000 Options expired
14/03/24 Ruediger Weseloh Expiry 600,000 $0.10 $60,000 Options expired
14/03/24 Marcus Frampton Expiry 600,000 $0.10 $60,000 Options expired
14/03/24 John Moore Expiry 1,200,000 $0.10 $120,000 Options expired
29/06/21 John Moore Issued 76,923 $0.26 $20,000 Placement
29/06/21 Peter Marks Issued 200,000 $0.26 $52,000 Placement
29/06/21 Marcus Frampton Issued 75,000 $0.26 $19,500 Placement
29/06/21 Ruediger Weseloh Issued 100,000 $0.26 $26,000 Placement
29/06/21 Ian Dixon Issued 192,308 $0.26 $50,000 Placement
29/06/21 Christopher Cox Issued 625,000 $0.26 $162,500 Placement
02/03/21 John Moore Buy +19,000 $0.35 $6,650 On-market trade
02/03/21 John Moore Buy +500 $0.204 $102 As advised by the company
23/02/21 Marcus Frampton Buy +25,000 $0.357 $8,925 On-market trade
18/01/21 Ian Dixon Issued 1,800,000 $0.40 $720,000 Director remuneration
25/11/20 John Moore Buy +32,000 $0.206 $6,600 On-market trade
24/11/20 Marcus Frampton Buy +35,000 $0.21 $7,350 On-market trade
10/09/20 John Moore Buy +32,500 $0.21 $6,825 On-market trade
23/04/20 John Moore Buy +35,000 $0.168 $5,882 On-market trade
Show All

Director Interests

The current holdings of NYR directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Marcus Frampton 12/06/2024 1,178,408 N/A 1,200,000 N/A
Ruediger Weseloh 12/06/2024 366,666 N/A 1,200,000 N/A
John Moore 12/06/2024 1,691,756 N/A 2,400,000 N/A
Ian Dixon 12/06/2024 N/A 10,380,699 1,800,000 N/A
Christopher Cox 14/03/2024 N/A 1,425,000 1,200,000 N/A
Gisela Mautner 01/08/2022 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 7, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Noxopharm Limited 33,373,245 21.39%
Altnia Holding Pty Ltd<I Dixon Family A/C> 9,921,725 6.36%
Sunset Capital Management Pty Ltd <Sunset Superfund A/C> 2,400,000 1.54%
Kyriaco Barber Pty Ltd 1,982,498 1.27%
Colin Housely & Freda Housely <Cm Housley & Fv Housley Fam> 1,863,725 1.19%
Superhero Securities Limited <Client A/C> 1,793,715 1.15%
Himstedt & Co Pty Ltd <The Himstedt Family A/C> 1,760,500 1.13%
Mr Nicholas John Axam 1,731,400 1.11%
Symphony Capital Holdings Llc 1,425,000 0.91%
Professor Gary David Housley 1,411,411 0.90%
Mr John Gardner 1,400,000 0.90%
Harlund Investments Pty Ltd <Hart Family Super Fund A/C> 1,400,000 0.90%
Dossman Pty Ltd 1,353,705 0.87%
Mr Anthony John Locantro 1,327,567 0.85%
John W King Nominees Pty Ltd 1,242,483 0.80%
Rhlc Pty Limited <Rhlc S/F A/C> 1,210,000 0.78%
Mr Colin James Easterbrook & Mrs Janet Elizabeth Easterbrook <C & J Easterbrook Super A/C> 1,200,000 0.77%
Canary Capital Pty Ltd 1,134,615 0.73%
Dixson Trust Pty Limited 1,100,000 0.71%
Mr Graham Arthur Robinson 1,082,888 0.69%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

No Substantial Shareholders for NYR in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.059 28 June
2023 $0.028 30 June
2022 $0.135 30 June
2021 $0.32 30 June
2020 $0.175 30 June
NYR Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.